Form D · Biotechnology
BACTERIN INTERNATIONAL, INC.
Belgrade, MT · CIK 0001083672
Offering snapshot reported Jun 21, 2010 · SEC filing
- Reported sold
- $1.09M Offering amount: $1.25M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- May 6, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 21, 2010 | Initial | $1,086,000 | No comparison | 7 | SEC filing |
| Apr 14, 2010 | Amendment | $3,475,000 | $475,000vs Mar 4, 2010 | 27 | SEC filing |
| Mar 4, 2010 | Amendment | $3,000,000 | $700,000vs Feb 8, 2010 | 23 | SEC filing |
| Feb 8, 2010 | Amendment | $2,300,000 | $900,000vs Jan 28, 2010 | 17 | SEC filing |
| Jan 28, 2010 | Initial | $1,400,000 | No comparison | 8 | SEC filing |
| Sep 28, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 26, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $100K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-143790
Represents 8% of the maximum offering amount of $1,250,000.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Middlebury Securities LLC | 122602 | |
| Axiom Capital Management, Inc. | 26580 |
Source: Form D, filed Jun 21, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Guy S. Cook | Director, Executive |
| Mitchell T. Godfrey | Director, Executive |
| Kent Swanson | Director |
| Steve B. Warnecke | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
600 Cruiser Lane
Belgrade, MT, 59714
Belgrade, MT, 59714